FAH and hepatocellular carcinoma: Reduced HCC development in Fah−/− mice was attributed to compensatory induction of Sestrin2, which promotes p62-dependent autophagic degradation of KEAP1, leading to NRF2 activation, protection from oxidative damage, and neoplastic transformation [39].